Cardinal Health (NYSE:CAH) CAO Sells $546,471.78 in Stock

Cardinal Health, Inc. (NYSE:CAH) CAO Mary Scherer sold 2,302 shares of the business’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total value of $546,471.78. Following the completion of the transaction, the chief accounting officer owned 2,811 shares in the company, valued at approximately $667,303.29. This trade represents a 45.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Cardinal Health Trading Down 2.5%

NYSE CAH traded down $5.90 during mid-day trading on Thursday, reaching $228.95. 1,588,640 shares of the company’s stock traded hands, compared to its average volume of 2,033,699. Cardinal Health, Inc. has a 1-year low of $145.87 and a 1-year high of $258.30. The company has a fifty day simple moving average of $231.76 and a 200-day simple moving average of $217.68. The company has a market cap of $53.25 billion, a price-to-earnings ratio of 31.67, a P/E/G ratio of 1.26 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.Cardinal Health’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 12.54 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio is currently 28.49%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CAH shares. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Morgan Stanley lifted their price target on Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Barclays boosted their price objective on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, August 13th. Robert W. Baird increased their target price on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a report on Wednesday, August 12th. Finally, William Blair assumed coverage on Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating for the company. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $266.56.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of CAH. BlackRock Inc. bought a new stake in shares of Cardinal Health during the 2nd quarter valued at about $6,293,115,000. Wellington Management Group LLP lifted its holdings in Cardinal Health by 247.5% in the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after acquiring an additional 10,584,119 shares during the last quarter. Norges Bank bought a new position in Cardinal Health in the fourth quarter worth about $790,344,000. Bank of America Corp DE acquired a new position in Cardinal Health in the second quarter valued at approximately $689,066,000. Finally, Legal & General Group Plc bought a new position in shares of Cardinal Health during the second quarter valued at approximately $438,870,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: RBC Capital began coverage with an “outperform” or “moderate buy” rating, citing Cardinal Health’s integration of higher-margin services as a potential driver of earnings and revenue outperformance. RBC Capital Starts Cardinal Health at Outperform
• Positive Sentiment: A separate value-oriented analysis highlighted CAH’s long-term investment appeal, while recent results showed adjusted earnings per share of $2.91, well above the $2.42 consensus estimate, and full-year adjusted free cash flow of approximately $5 billion. Why Cardinal Health is a Top Value Stock for the Long-Term
• Neutral Sentiment: Brokerages collectively maintain a “moderate buy” consensus rating. However, analysts and investors may be examining the quality of the earnings beat because part of the quarterly benefit came from a one-time tariff refund, making the 40% year-over-year adjusted EPS growth less representative of recurring performance. Cardinal Health’s Big Earnings Beat Hides a More Complicated Story
• Negative Sentiment: Multiple executives and insiders reported sizable stock sales executed around $235–$236 per share. CEO Jason M. Hollar sold 124,529 shares across two transactions, while CEO Deborah Weitzman, Stephen M. Mason, Michelle D. Greene, and Jessica L. Mayer also reduced their holdings. The volume and concentration of these sales may be weighing on sentiment, although insider transactions can reflect diversification or scheduled selling rather than a change in business outlook. Cardinal Health Insider Transaction Filing

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.